Carolyn Cross, Ondine Biomedical Inc.

Carolyn Cross is the Founder, Chairman and Chief Executive Officer of Ondine Biomedical Inc., a Vancouver based medical devices company. Ms. Cross just completed a term on the National Research Council of Canada and is a Board Member and Treasurer of the International Photodynamic Association.

Earlier in her career, Ms. Cross was responsible for managing pension, pooled, mutual and private client funds as a Vice President with Royal Bank Investment Management Inc. Ms. Cross has over 25 years’ direct experience with early stage companies and 30 years’ experience with public market securities. Ms. Cross is a Chartered Financial Analyst (CFA), and has an MBA from York University and an HBA from the University of Western Ontario.

She currently advises and sits on a number of corporate boards including Greystone Capital Management Inc., Periowave Dental Technologies Inc., Sinuwave Technologies Corporation, and Cayoose Creek Development Corporation, a First Nations company based in British Columbia. She is a past Board Member of the Canadian Foundation for Innovation (CFI) and past member of its Audit and Finance Committee. She sits on the Advisory Council of the University of Windsor’s Odette World Health Innovation Network (WIN) and had served on the Advisory Board of McGill University Dental School for 8 years. She is the Chairman and Founding Board Member of the Women’s Economic Business Advisory Council and a Founding Member of the EY Global Women in Business Advisory Council. She recently served on the Federal Government’s task force on Women’s Entrepreneurship and Mentoring and continues to advocate for SME and the economic advancement of women in Canada. Ms. Cross is a member of several organizations including the Women Presidents’ Organization, the International Federation of Women (IWF), UnitedSucces and the CFA Society Toronto. Ms. Cross was awarded the Meritorious Service Cross by the Governor General of Canada, and is a recipient of awards including the Queen Elizabeth II Diamond Jubilee Award from the Government of Canada, the President’s Award from the Women Presidents’ Organization and the Innovation and Global Growth Award from The BMO Financial Group.

Ondine Biomedical Inc. is the global leader in Photodisinfection, a revolutionary approach to rapidly eliminate infection-causing pathogens without adverse side-effects or generating antimicrobial resistance. Ondine's mission is to save lives and reduce suffering of millions of people by developing effective non-antibiotic, anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections, Its life-saving and award-winning Photodisinfection technology is already helping 2 Canadian hospitals reduce surgical site infections by nearly 80%.